Changes to the Poisons and Therapeutic Goods Act 1966 earlier this year created a new classification for medicines used in cosmetic procedures, such as anti-wrinkle injections and dermal fillers.
NSW Health is now considering the content of the tailored regulations which could be introduced in relation to medicines in this new classification.
These regulations may deal with matters relating to the possession, manufacture, supply, use, prescription, administration, storage and disposal of botulinum toxin and hyaluronic acid dermal fillers.
Invitation to comment on proposed changes
The public is invited to provide preliminary comments regarding:
- the types of rules relating to anti-wrinkle injections and dermal fillers that could be introduced under the amendments to the Act to protect consumers against unsafe practices
- whether any other cosmetic products (in addition to anti-wrinkle injections and dermal fillers) should also be subject to additional regulation
- any other issue related to the development of these new regulations
NSW Health recognises the majority of cosmetic service providers operate in a safe and appropriate manner. The additional regulations are intended to target the minority of providers who adopt unsafe practices which compromise patient safety and can have serious consequences for patients.
If you have already made a submission to the Minister or NSW Health regarding these changes, your comments will be considered as part of this feedback process and you do not need to make another submission at this stage. However, you are welcome to provide a further comments if you would like.
NSW Health will be preparing draft regulations in relation to anti-wrinkle injections and dermal fillers once it has considered these comments. Once drafted, the regulations will be made available for feedback on the NSW Health website. Stakeholders who provide comments will be notified of the publication of the draft regulations by email.
Please make a submission online or email your comments to MOHfirstname.lastname@example.org by 5pm on Monday, 17 September 2018.